semaglutide effect on kidneys in Diabetic Kidney Disease: Integrating Clinical Evidence with Mechanistic Insights In this analysis of FLOW

Weight gain may also lead to dysregulation of the GLP1 system and contribute to the maintenance of metabolic dysfunction (Ranganath et al., 1996)

Consistent moderate deficits produce better long-term outcomes than alternating between very low intake and compensatory eating

Hertzel Gerstein, a professor in the medicine department at McMaster University and a diabetes physician, noted that the process of approving generic GLP-1 drugs into public drug plans differs by province, and it is not yet clear whether generic semaglutide will be covered [Source: globalnews.ca/news/11820779/canada-approves-1st-generic-ozempic-market/]

Does Oral Liposomal Glutathione Increase Glutathione Levels and Antioxidant Activity

Hy's law: predicting serious hepatotoxicity

Stem Cells Int 2016 , 1740936 (2016)